Optimizing Treatment Strategies for Metastatic NSCLC: Achieving the Best Patient Outcomes : Episode 10
Patient Education and Guidance on Lorlatinib and Other ALK Inhibitors
Key opinion leaders focus on educating patients about potential side effects of lorlatinib and other ALK inhibitors, including guidance on when to contact their care team.
Video content above is prompted by the following:
- How do you educate patients on potential side effects of lorlatinib and other ALK inhibitors?
- What guidance do you provide about when to reach out to their care team?
Recent Videos
Related Content
